Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis

References

• Organization WH. Cervical cancer key facts. 2022.
   Google Scholar
• Forster AS. The human papillomavirus immunization program and sexual behavior. UCL (University College London); 2011.
   Google Scholar
• Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–10. doi:10.1016/j.currproblcancer.2018.06.003.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):191–203. doi:10.1016/S2214-109X(19)30482-6.
   PubMed Web of Science ®Google Scholar
• Organization WH. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization; 2020.
   Google Scholar
• Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22(1). doi:10.11604/pamj.2015.22.26.7116.
   PubMedGoogle Scholar
• G M-F. Cervical cancer knowledge and risk behaviors among students of the University of Port Harcourt, Nigeria. 2016.
   Google Scholar
• Duncan J, Harris M, Skyers N, Bailey A, Figueroa JP. A call for low-and middle-income countries to commit to the elimination of cervical cancer. Lancet Reg Health–Am. 2021;2:100036. doi:10.1016/j.lana.2021.100036.
   PubMedGoogle Scholar
• Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30:123–38. doi:10.1016/j.vaccine.2012.04.108.
   PubMed Web of Science ®Google Scholar
• Ault KA. Human papillomavirus vaccines: an update for gynecologists. Clin Obstet Gynecol. 2008;51(3):527–32. doi:10.1097/GRF.0b013e31818092df.
   PubMed Web of Science ®Google Scholar
• Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis. 2004;10(11):1915. doi:10.3201/eid1011.040222.
   PubMed Web of Science ®Google Scholar
• Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily M-C, Baldo V, Brassard P, Brotherton JML, Callander D. et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programs: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509. doi:10.1016/S0140-6736(19)30298-3.
   PubMed Web of Science ®Google Scholar
• Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, Verma Y, Esmy PO, Poli URR, Shah A, et al. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol. 2021;22(11):1518–29. doi:10.1016/S1470-2045(21)00453-8.
   PubMed Web of Science ®Google Scholar
• LaMontagne DS, Barge S, Thi Le N, Mugisha E, Penny ME, Gandhi S, Janmohamed A, Kumakech E, Mosqueira NR, Nguyen NQ, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ. 2011;89(11):821–30. doi:10.2471/BLT.11.089862.
   PubMed Web of Science ®Google Scholar
• Loke AY, Kwan ML, Wong Y-T, Wong AKY. The uptake of human papillomavirus vaccination and its associated factors among adolescents: a systematic review. J Prim Care Community Health. 2017;8(4):349–62. doi:10.1177/2150131917742299.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. doi:10.1016/j.ijsu.2021.105906.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Jama. 2000;283(15):2008–12. doi:10.1001/jama.283.15.2008.
   PubMed Web of Science ®Google Scholar
• Modesti P, Reboldi G, Cappuccio F. Newcastle-Ottawa quality assessment scale (adapted for cross-sectional studies). PLoS One. 2016;11(1):e0147601. doi:10.1371/journal.pone.0147601.
   PubMed Web of Science ®Google Scholar
• Ezeanochie M, Olasimbo P. Awareness and uptake of human papillomavirus vaccines among female secondary school students in Benin City, Nigeria. Afr Health Sci. 2020;20(1):45–50. doi:10.4314/ahs.v20i1.8.
   PubMed Web of Science ®Google Scholar
• Iliyasu Z, Galadanci HS, Muhammad A, Iliyasu BZ, Umar AA, Aliyu MH. Correlates of human papillomavirus vaccine knowledge and acceptability among medical and allied health students in Northern Nigeria. J Obstet Gynaecol. 2022;42(3):452–60. doi:10.1080/01443615.2021.1910639.
   PubMedGoogle Scholar
• Mohammed A, Tukur A, Osagie A, Okoh E. Uptake of human papilloma virus vaccine among students of tertiary institutions in Gombe State, Nigeria.
   Google Scholar
• Ndikom C, Oboh P. Perception, acceptance and uptake of human papillomavirus vaccine among female adolescents in selected secondary schools in Ibadan, Nigeria. Afr J Biomed Res. 2017;20:237–44.
   Google Scholar
• Ogunlaja O, Akinola S, Aworinde O, Ogunlaja I, Bojuwoye M. Knowledge and uptake of human papilloma virus vaccine for prevention of cervical cancer among secondary school females in Ogbomoso, South West Nigeria. Editorial Board. 2018;3427.
   Google Scholar
• Beyen M, Bulto GA, Chaka EE, Debelo BT, Roga EY, Wakgari N, Danusa KT, Fekene DB. Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020. PLoS One. 2022;17(7):e0271237. doi:10.1371/journal.pone.0271237.
   PubMedGoogle Scholar
• Kassa HN, Bilchut AH, Mekuria AD, Lewetie EM. Practice and associated factors of human papillomavirus vaccination among primary school students in Minjar-Shenkora District, North Shoa Zone, Amhara Regional State, Ethiopia, 2020. Cancer Manag Res. 2021;13:6999–7008. doi:10.2147/CMAR.S324078.
   PubMed Web of Science ®Google Scholar
• Lakneh EA, Mersha EA, Asresie MB, Belay HG, Okunade KS. Knowledge, attitude, and uptake of human papillomavirus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia. PLoS One. 2022;17(11):e0276465. doi:10.1371/journal.pone.0276465.
   PubMed Web of Science ®Google Scholar
• Terefe GTE, Shambo B. Knowledge, attitude and uptake of human papillomavirus vaccination and its associated factors among adolescent school girls in Wolaita Sodo town, Southern Ethiopia. 2022.
   Google Scholar
• Aruho C, Mugambe S, Baluku JB, Taremwa IM. Human papillomavirus vaccination uptake and its predictors among female adolescents in Gulu Municipality, Northern Uganda. Adolesc Health Med Ther. 2022;13:77–91. doi:10.2147/AHMT.S383872.
   PubMed Web of Science ®Google Scholar
• Bitariho GK, Tuhebwe D, Tigaiza A, Nalugya A, Ssekamatte T, Kiwanuka SN. Knowledge, perceptions, and uptake of human papillomavirus vaccine among adolescent girls in Kampala, Uganda; a mixed-methods school-based study. BMC Pediatr. 2023;23(1):368. doi:10.1186/s12887-023-04174-z.
   PubMed Web of Science ®Google Scholar
• Nabirye J, Okwi LA, Nuwematsiko R, Kiwanuka G, Muneza F, Kamya C, Babirye JN. Health system factors influencing uptake of human papilloma virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda. BMC Public Health. 2020;20:1–11. doi:10.1186/s12889-020-8302-z.
   PubMed Web of Science ®Google Scholar
• Odongo Ojok I, Ogwal JB, Wwesige B, Bongomin F, Akello F. Factors associated with the human papillomavirus vaccine coverage in Gulu District, Uganda. Adolesc Health Med Ther. 2023;14:87–96. doi:10.2147/AHMT.S397734.
   PubMed Web of Science ®Google Scholar
• Mabeya H, Menon S, Weyers S, Naanyu V, Mwaliko E, Kirop E, Orango O, Vermandere H, Vanden Broeck D. Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting. BMC Cancer. 2018;18(1):1–7. doi:10.1186/s12885-018-4382-x.
   PubMedGoogle Scholar
• Vermandere H, Naanyu V, Mabeya H, Vanden Broeck D, Michielsen K, Degomme O, Consolaro MEL. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. PLoS One. 2014;9(10):e109353. doi:10.1371/journal.pone.0109353.
   PubMed Web of Science ®Google Scholar
• Ayissi CA, Wamai RG, Oduwo GO, Perlman S, Welty E, Welty T, Manga S, Ogembo JG. Awareness, acceptability, and uptake of human papillomavirus vaccine among Cameroonian school-attending female adolescents. J Community Health. 2012;37:1127–35. doi:10.1007/s10900-012-9554-z.
   PubMed Web of Science ®Google Scholar
• Mendes Lobão W, Duarte FG, Burns JD, de Souza Teles Santos CA, Chagas de Almeida MC, Reingold A, Duarte Moreira E. Low coverage of HPV vaccination in the national immunization program in Brazil: parental vaccine refusal or barriers in health-service based vaccine delivery? PLoS One. 2018;13(11):e0206726. doi:10.1371/journal.pone.0206726.
   PubMed Web of Science ®Google Scholar
• Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8(4):e019206. doi:10.1136/bmjopen-2017-019206.
   PubMed Web of Science ®Google Scholar
• Brotherton JM, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, Pitcher HC, Scully MM, Molchanoff L. Human papillomavirus vaccine coverage among female Australian adolescents: the success of the school‐based approach. Med J Aust. 2013;199(9):614–7. doi:10.5694/mja13.10272.
   PubMed Web of Science ®Google Scholar
• Karanja-Chege CM. HPV vaccination in Kenya: the challenges faced and strategies to increase uptake. Front Public Health. 2022;10:802947. doi:10.3389/fpubh.2022.802947.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y, Nie S. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016;16(1):1–15. doi:10.1186/s12889-016-2873-8.
   PubMedGoogle Scholar
• Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43(3):239–45. doi:10.1016/j.jadohealth.2008.06.009.
   PubMed Web of Science ®Google Scholar
• Faisal-Cury A, Levy RB, Tourinho MF, Grangeiro A, Eluf-Neto J. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program. BMC Public Health. 2020;20(1):1–12. doi:10.1186/s12889-020-08561-4.
   PubMed Web of Science ®Google Scholar
• Donati S, Giambi C, Declich S, Salmaso S, Filia A, Degli Atti MLC, Alibrandi MP, Brezzi S, Carozzi F, Collina N, et al. Knowledge, attitude, and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine. 2012;30(12):2075–82. doi:10.1016/j.vaccine.2012.01.057.
   PubMed Web of Science ®Google Scholar
• Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–56. doi:10.1016/j.vaccine.2012.03.063.
   PubMed Web of Science ®Google Scholar
• Hardt K, Bonanni P, King S, Santos JI, El-Hodhod M, Zimet GD, Preiss S. Vaccine strategies: optimising outcomes. Vaccine. 2016;34(52):6691–9. doi:10.1016/j.vaccine.2016.10.078.
   PubMed Web of Science ®Google Scholar
• Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Db Syst Rev. 2020;2020(1). doi:10.1002/14651858.CD011895.pub2.
   Google Scholar